Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
56,879,540
-
Share change
-
-210,386
-
Total reported value
-
$7,407,482,783
-
Put/Call ratio
-
118%
-
Price per share
-
$130.21
-
Number of holders
-
422
-
Value change
-
-$119,725,201
-
Number of buys
-
183
-
Number of sells
-
263
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2021
As of 30 Sep 2021,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
422 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,879,540 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, FMR LLC, JPMORGAN CHASE & CO, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, Polaris Capital Management, LLC, LSV ASSET MANAGEMENT, and CANADA PENSION PLAN INVESTMENT BOARD.
This page lists
423
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.